Brustugun OT, Grønberg BH, Aanerud M, Paulsen EE, Fjellbirkeland L(2025) Lung Cancer in Norway J Thorac Oncol, 20(7), 839-846 DOI 10.1016/j.jtho.2025.03.046, PubMed 40617667
Hoffmann-Vold AM, Petelytska L, Fretheim H, Aaløkken TM, Becker MO, Jenssen Bjørkekjær H, Brunborg C, Bruni C, Clarenbach C, Diep PP, Dobrota R, Durheim MT, Elhai M, Frauenfelder T, Huang S, Jordan S, Langballe E, Midtvedt Ø, Mihai C, Mulcaire-Jones E, Pugashetti JV, Sprecher M, Oldham J, Molberg Ø, Khanna Det al.(2025) Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study Lancet Rheumatol, 7(7), e463-e471 DOI 10.1016/S2665-9913(25)00026-8, PubMed 40381640
Nyen JE, Booth AØ, Husby Ø, Bugge C, Engebretsen I, Oteiza F, Helland Å, Fjellbirkeland L, Brustugun OT, Grønberg BH(2025) Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study Front Oncol, 15, 1595028 DOI 10.3389/fonc.2025.1595028, PubMed 40206591
